ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Psychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs).

Ilaria Ammendolia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.